TORM plc Long-Term Incentive Program
In accordance with TORM plc’s (“TORM”) Remuneration Policy adopted by the Annual General Meeting of TORM plc on 12 April […]
Monro, Inc. to Report Fourth Quarter and Fiscal 2020 Earnings on May 28, 2020
ROCHESTER, N.Y., May 15, 2020 (GLOBE NEWSWIRE) — Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and […]
Aprea Therapeutics Reports First Quarter 2020 Financial Results and Provides Update on Business Operations
BOSTON, May 15, 2020 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel […]
Seelos Therapeutics Receives Rare Pediatric Disease Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome
NEW YORK, May 15, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the […]
ContraFect Reports First Quarter 2020 Financial Results and Provides Business Update
YONKERS, N.Y., May 15, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Surface Oncology to Present Preclinical Data for Multiple Product Programs at the American Association for Cancer Research Annual Meeting
CAMBRIDGE, Mass., May 15, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target […]
Orgenesis Announces Stock Repurchase Plan of Up to $10 Million
GERMANTOWN, Md., May 15, 2020 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering global biotech […]
The Joint Corp. to Participate in the 17th Annual Craig-Hallum Institutional Investor Conference
SCOTTSDALE, Ariz., May 15, 2020 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of […]
New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting II
AUSTIN, Texas,, May 15, 2020 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company […]
Neoleukin Therapeutics Announces Multiple Presentations at American Association for Cancer Research (AACR) Virtual Annual Meeting II
-Preclinical Data on Lead Immunotherapy Candidate NL-201 Including Immunogencity Results in Non-Human Primates-SEATTLE, May 15, 2020 (GLOBE NEWSWIRE) — Neoleukin […]
